Meta Pixel

News and Announcements

Going for growth and the greater fool: How a value manager turned the tables and topped the charts

  • Published November 21, 2019 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

2019 has, in the eyes of most financial commentators, been a typical ‘growth’ market. Momentum driven names in the typically ‘growth’ centric technology sector has seen some price to earnings multiples blow out to nearly 200 times their forecast earnings…….in 2021!

So how, when faced with such extreme price action in the ‘growth’ segment of the ASX has the Collins St Value Fund not only risen to the top of the ‘value’ leaderboard but as at 31 October 2019 outperformed all of the ‘growth’ funds in Morningstar’s large-cap universe as well?

Quite simply, by doing things differently.

Underpinned by a patient, objective and high conviction stock selection process, the Portfolio Managers at the Collins St Value Fund have the freedom to pursue only the absolute best investment ideas at any one point in time. Indeed, current portfolio weightings are entirely outside of the ASX top 20, with a skew towards a bespoke blend of uranium companies, small-mid cap gold miners, financial services stocks and pharmaceutical/health care holdings. The portfolio also currently has a material cash weighting that can be rapidly deployed should sound business models and industry dynamics make themselves available at heavily discounted entry points.

At a more granular level, low price to earnings multiples, low debt to equity, proven business models and credible management are what the Portfolio Managers are looking for in a company. Thoughtful consideration, not reckless speculation, is what the Portfolio Managers believe will drive superior investor outcomes.

The extent of the Collins St Value Fund’s outperformance has been significant.

For the 12 month rolling period to 31 October 2019 on an after-fee basis (and as measured by Morningstar) the Collins St Value Fund returned 42.41% after fees for the 12 month period to 31 October 2019. That’s 15.57% ahead of its nearest growth rival, 19.98% ahead of its nearest value rival and 23.13% above the S&P ASX 200 Index.

With no fixed management fees underpinning an unwavering focus on capital preservation, capacity management and superior portfolio returns, the Portfolio Managers at the Collins St Value Fund are excited by the opportunities current financial uncertainties are presenting and look forward on building upon the success of 2019 into the future.

 

The Collins St Value Fund aims to preserve and grow the wealth of private investors and their families both now and for future generations. The Fund, which has delivered ~20% gross returns p.a. since establishment in 2016, seeks to achieve this goal through a bespoke combination of patience, conviction, freedom and objectivity.

Register Interest

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now